Lifecore Biomedical, Inc. De (LFCR) Profit After Tax (2010 - 2025)

Lifecore Biomedical's Profit After Tax history runs 16 years deep, the most recent figure standing at -$1.1 million for Q2 2025.

• In Q2 2025, Profit After Tax rose 88.25% year-over-year to -$1.1 million; the TTM figure through May 2025 stood at -$38.7 million (down 514.93% YoY), while the FY2025 annual figure was -$38.7 million, down 514.93% from the prior year.
• Profit After Tax was -$1.1 million for Q2 2025 at Lifecore Biomedical, up from -$14.8 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $15.6 million in Q1 2024 to a low of -$37.0 million in Q2 2023.
• Historically, Profit After Tax has averaged -$7.9 million across 5 years, with a median of -$7.6 million in 2021.
• Biggest YoY gain for Profit After Tax was 211.03% in 2023; the steepest drop was 919.23% in 2023.
• A 5-year view of Profit After Tax shows it stood at $7.5 million in 2021, then sank by 269.68% to -$12.8 million in 2022, then jumped by 211.03% to $14.2 million in 2023, then slumped by 146.22% to -$6.6 million in 2024, then soared by 82.54% to -$1.1 million in 2025.
• The last three Profit After Tax figures came in at -$1.1 million (Q2 2025), -$14.8 million (Q1 2025), and -$6.6 million (Q4 2024), per Business Quant data.